TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Euroform MediPharm AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
32,315
|
33,866
|
34,726 |
Financial expenses |
1
|
113
|
392 |
Earnings before taxes |
491
|
-3,339
|
-11,647 |
EBITDA |
1,105
|
-2,434
|
-4,497 |
Total assets |
24,458
|
23,424
|
26,905 |
Current assets |
21,668
|
20,322
|
22,855 |
Current liabilities |
9,605
|
8,892
|
11,491 |
Equity capital |
14,686
|
14,195
|
14,959 |
- share capital |
101
|
95
|
98 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.0%
|
60.6%
|
55.6% |
Turnover per employee |
2,486
|
2,605
|
2,894 |
Profit as a percentage of turnover |
1.5%
|
-9.9%
|
-33.5% |
Return on assets (ROA) |
2.0%
|
-13.8%
|
-41.8% |
Current ratio |
225.6%
|
228.5%
|
198.9% |
Return on equity (ROE) |
3.3%
|
-23.5%
|
-77.9% |
Change turnover |
-3,954
|
184
|
6,376 |
Change turnover % |
-11%
|
1%
|
22% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.